Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Evaluation of antibody response to polysaccharide vaccine and switched memory B cells in pediatric patients with inflammatory bowel disease.

Fallahi G, Aghamohammadi A, Khodadad A, Hashemi M, Mohammadinejad P, Asgarian-Omran H, Najafi M, Farhmand F, Motamed F, Soleimani K, Soheili H, Parvaneh N, Darabi B, Nasiri Kalmarzi R, Pourhamdi S, Abolhassani H, Mirminachi B, Rezaei N.

Gut Liver. 2014 Jan;8(1):24-8. doi: 10.5009/gnl.2014.8.1.24. Epub 2013 Aug 14.

2.

Immunogenecity of hepatitis A and B vaccination in pediatric patients with inflammatory bowel disease.

Urganci N, Kalyoncu D.

J Pediatr Gastroenterol Nutr. 2013 Apr;56(4):412-15. doi: 10.1097/MPG.0b013e31827dd87d.

PMID:
23841120
3.

Immunoglobulin M memory B cell decrease in inflammatory bowel disease.

Di Sabatino A, Carsetti R, Rosado MM, Ciccocioppo R, Cazzola P, Morera R, Tinozzi FP, Tinozzi S, Corazza GR.

Eur Rev Med Pharmacol Sci. 2004 Sep-Oct;8(5):199-203.

PMID:
15638230
4.

Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.

Sýkora J, Subrt I, Dìdek P, Siala K, Schwarz J, Machalová V, Varvarovská J, Pazdiora P, Pozler O, Stozický F.

J Pediatr Gastroenterol Nutr. 2006 May;42(5):479-87.

PMID:
16707968
5.

Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study.

Fiorino G, Peyrin-Biroulet L, Naccarato P, Szabò H, Sociale OR, Vetrano S, Fries W, Montanelli A, Repici A, Malesci A, Danese S.

Inflamm Bowel Dis. 2012 Jun;18(6):1042-7. doi: 10.1002/ibd.21800. Epub 2011 Jun 14.

PMID:
21674732
6.

Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.

Seow CH, Stempak JM, Xu W, Lan H, Griffiths AM, Greenberg GR, Steinhart AH, Dotan N, Silverberg MS.

Am J Gastroenterol. 2009 Jun;104(6):1426-34. doi: 10.1038/ajg.2009.79. Epub 2009 Apr 21.

PMID:
19491856
7.

Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis.

Gurbindo C, Sabbah S, Menezes J, Justinich C, Marchand R, Seidman EG.

J Pediatr Gastroenterol Nutr. 1993 Oct;17(3):247-54.

PMID:
8271122
8.

Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.

Horton N, Wu X, Philpott J, Garber A, Achkar JP, Brzezinski A, Lashner BA, Shen B.

Dig Dis Sci. 2016 Nov;61(11):3270-3277. Epub 2016 Sep 12.

PMID:
27619393
9.

Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. A cross-sectional study with matching.

Parente F, Molteni P, Bollani S, Maconi G, Vago L, Duca PG, Rembacken B, Axon AT, Bianchi Porro G.

Scand J Gastroenterol. 1997 Nov;32(11):1140-6.

PMID:
9399396
10.

Mucosal IgG4 cell infiltration in ulcerative colitis is linked to disease activity and primary sclerosing cholangitis.

Raina A, Yadav D, Regueiro M, Krasinskas AM, Saul MI, Sapienza DA, Binion DG, Hartman DJ.

Inflamm Bowel Dis. 2013 May;19(6):1232-7. doi: 10.1097/MIB.0b013e318281344d.

PMID:
23619716
11.

Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.

North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; Colitis Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, Griffiths AM, Jevon GP, Higuchi LM, Hyams JS, Kirschner BS, Kugathasan S, Baldassano RN, Russo PA.

J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74.

PMID:
17460505
12.

CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.

Brandhorst G, Weigand S, Eberle C, Raddatz D, Karaus M, Oellerich M, Walson PD.

Clin Chim Acta. 2013 Jun 5;421:31-3. doi: 10.1016/j.cca.2013.02.016. Epub 2013 Feb 26.

PMID:
23485644
13.

Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature.

Reddy H, Shipman AR, Wojnarowska F.

Clin Exp Dermatol. 2013 Apr;38(3):225-9; quiz 229-30. doi: 10.1111/ced.12114. Review.

PMID:
23517353
14.

Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value.

Olives JP, Breton A, Hugot JP, Oksman F, Johannet C, Ghisolfi J, Navarro J, Cézard JP.

J Pediatr Gastroenterol Nutr. 1997 Aug;25(2):142-8.

PMID:
9252899
15.
16.

Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.

Beltrán CJ, Candia E, Erranz B, Figueroa C, Gonzalez MJ, Quera R, Hermoso MA.

Eur Cytokine Netw. 2009 Mar;20(1):33-8. doi: 10.1684/ecn.2009.0142. Erratum in: Eur Cytokine Netw. 2009 Jun;20(2):94.

17.
18.
19.

Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.

Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I.

Gut. 1996 Mar;38(3):365-75.

20.

[The expression of peripheral Th1 and Th17 cells in inflammatory bowel disease and its potential clinical value].

Dai J, Zhang GB, Gao N, Xi QH, Li YQ, Pang Z, Zhao Y, Zhao JM, Nie JS, Chen WC.

Zhonghua Nei Ke Za Zhi. 2013 May;52(5):375-8. Chinese.

PMID:
23945300

Supplemental Content

Support Center